Publicacións en colaboración con investigadores/as de Universidad Complutense de Madrid (13)

2022

  1. Inhibition of carnitine palmitoyltransferase 1A in hepatic stellate cells protects against fibrosis

    Journal of Hepatology, Vol. 77, Núm. 1, pp. 15-28

  2. Temperature modulates systemic and central actions of thyroid hormones on BAT thermogenesis

    Frontiers in Physiology, Vol. 13

2021

  1. BMP8 and activated brown adipose tissue in human newborns

    Nature Communications, Vol. 12, Núm. 1

  2. Orally induced hyperthyroidism regulates hypothalamic amp-activated protein kinase

    Nutrients, Vol. 13, Núm. 12

2020

  1. HYPOTHesizing about central comBAT against obesity

    Journal of Physiology and Biochemistry, Vol. 76, Núm. 2, pp. 193-211

2019

  1. Glucagon, GLP-1 and thermogenesis

    International Journal of Molecular Sciences, Vol. 20, Núm. 14

2018

  1. Genetic targeting of GRP78 in the VMH improves obesity independently of food intake

    Genes, Vol. 9, Núm. 7

2007

  1. Critical assessment of the current guidelines for the management and treatment of morbidly obese patients

    Journal of Endocrinological Investigation, Vol. 30, Núm. 10, pp. 844-852

1990

  1. GRF-induced GH response in attention-deficit hyperactivity disorder

    Methods and Findings in Experimental and Clinical Pharmacology, Vol. 12, Núm. 1, pp. 79-85

1989

  1. Activation of cholinergic neurotransmission by pyridostigmine reverses the inhibitory effect of hyperglycemia on growth hormone (GH) releasing hormone-induced GH secretion in man: Does acute hyperglycemia act through hypothalamic release of somatostatin?

    Neuroendocrinology, Vol. 49, Núm. 5, pp. 551-554

1986

  1. GROWTH HORMONE RESPONSES TO GRF 1–29 IN PATIENTS WITH PRIMARY HYPOTHYROIDISM BEFORE AND DURING REPLACEMENT THERAPY WITH THYROXINE

    Clinical Endocrinology, Vol. 24, Núm. 6, pp. 693-698

  2. INFLUENCE OF DOPAMINERGIC, ADRENERGIC AND CHOLINERGIC BLOCKADE AND TRH ADMINISTRATION ON GH RESPONSES TO GRF 1–29

    Clinical Endocrinology, Vol. 24, Núm. 3, pp. 291-298

1983

  1. Exaggerated circadian variation in basal thyrotropin (tsh) and in the dopaminergic inhibition of tsh release in pathological hyperprolactinemia: Evidence against a hypothalamic dopaminergic defect

    Journal of Clinical Endocrinology and Metabolism, Vol. 57, Núm. 5, pp. 975-980